Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

H. Pfeifer; G. Cazzaniga; V. H.J. van der Velden; J. M. Cayuela; B. Schäfer; O. Spinelli; S. Akiki; S. Avigad; I. Bendit; K. Borg; H. Cavé; L. Elia; S. C. Reshmi; G. Gerrard; S. Hayette; M. Hermanson; A. Juh; T. Jurcek; M. C. Chillón; C. Homburg; G. Martinelli; V. Kairisto; T. Lange; T. Lion; M. C. Mueller; F. Pane; L. Rai; C. Damm-Welk; T. Sacha; S. Schnittger; T. Touloumenidou; H. Valerhaugen; P. Vandenberghe; J. Zuna; H. Serve; E. Herrmann; S. Markovic; J. J.M. van Dongen; O. G. Ottmann

doi:10.1038/s41375-020-0707-2

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

H. Pfeifer^*, G. Cazzaniga, V. H.J. van der Velden, J. M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cavé, L. Elia, S. C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M. C. Chillón, C. HomburgG. Martinelli, V. Kairisto, T. Lange, T. Lion, M. C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J. J.M. van Dongen, O. G. Ottmann

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Pages (from-to)	1970
Number of pages	1
Journal	Leukemia
Volume	34
Issue number	7
DOIs	https://doi.org/10.1038/s41375-020-0707-2
State	Published - 1 Jul 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-020-0707-2

Fingerprint

Dive into the research topics of 'Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)'. Together they form a unique fingerprint.

Cite this

Pfeifer, H., Cazzaniga, G., van der Velden, V. H. J., Cayuela, J. M., Schäfer, B., Spinelli, O., Akiki, S., Avigad, S., Bendit, I., Borg, K., Cavé, H., Elia, L., Reshmi, S. C., Gerrard, G., Hayette, S., Hermanson, M., Juh, A., Jurcek, T., Chillón, M. C., ... Ottmann, O. G. (2020). Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0). Leukemia, 34(7), 1970. https://doi.org/10.1038/s41375-020-0707-2

Pfeifer, H. ; Cazzaniga, G. ; van der Velden, V. H.J. et al. / Correction : Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0). In: Leukemia. 2020 ; Vol. 34, No. 7. pp. 1970.

@article{dd287badaa6b4c9182de9e18277b87c7,

title = "Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "H. Pfeifer and G. Cazzaniga and {van der Velden}, {V. H.J.} and Cayuela, {J. M.} and B. Sch{\"a}fer and O. Spinelli and S. Akiki and S. Avigad and I. Bendit and K. Borg and H. Cav{\'e} and L. Elia and Reshmi, {S. C.} and G. Gerrard and S. Hayette and M. Hermanson and A. Juh and T. Jurcek and Chill{\'o}n, {M. C.} and C. Homburg and G. Martinelli and V. Kairisto and T. Lange and T. Lion and Mueller, {M. C.} and F. Pane and L. Rai and C. Damm-Welk and T. Sacha and S. Schnittger and T. Touloumenidou and H. Valerhaugen and P. Vandenberghe and J. Zuna and H. Serve and E. Herrmann and S. Markovic and {van Dongen}, {J. J.M.} and Ottmann, {O. G.}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Nature Limited.",

year = "2020",

month = jul,

day = "1",

doi = "10.1038/s41375-020-0707-2",

language = "אנגלית",

volume = "34",

pages = "1970",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

Pfeifer, H, Cazzaniga, G, van der Velden, VHJ, Cayuela, JM, Schäfer, B, Spinelli, O, Akiki, S, Avigad, S, Bendit, I, Borg, K, Cavé, H, Elia, L, Reshmi, SC, Gerrard, G, Hayette, S, Hermanson, M, Juh, A, Jurcek, T, Chillón, MC, Homburg, C, Martinelli, G, Kairisto, V, Lange, T, Lion, T, Mueller, MC, Pane, F, Rai, L, Damm-Welk, C, Sacha, T, Schnittger, S, Touloumenidou, T, Valerhaugen, H, Vandenberghe, P, Zuna, J, Serve, H, Herrmann, E, Markovic, S, van Dongen, JJM & Ottmann, OG 2020, 'Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)', Leukemia, vol. 34, no. 7, pp. 1970. https://doi.org/10.1038/s41375-020-0707-2

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0). / Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H.J. et al.
In: Leukemia, Vol. 34, No. 7, 01.07.2020, p. 1970.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

AU - Pfeifer, H.

AU - Cazzaniga, G.

AU - van der Velden, V. H.J.

AU - Cayuela, J. M.

AU - Schäfer, B.

AU - Spinelli, O.

AU - Akiki, S.

AU - Avigad, S.

AU - Bendit, I.

AU - Borg, K.

AU - Cavé, H.

AU - Elia, L.

AU - Reshmi, S. C.

AU - Gerrard, G.

AU - Hayette, S.

AU - Hermanson, M.

AU - Juh, A.

AU - Jurcek, T.

AU - Chillón, M. C.

AU - Homburg, C.

AU - Martinelli, G.

AU - Kairisto, V.

AU - Lange, T.

AU - Lion, T.

AU - Mueller, M. C.

AU - Pane, F.

AU - Rai, L.

AU - Damm-Welk, C.

AU - Sacha, T.

AU - Schnittger, S.

AU - Touloumenidou, T.

AU - Valerhaugen, H.

AU - Vandenberghe, P.

AU - Zuna, J.

AU - Serve, H.

AU - Herrmann, E.

AU - Markovic, S.

AU - van Dongen, J. J.M.

AU - Ottmann, O. G.

PY - 2020/7/1

Y1 - 2020/7/1

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

UR - http://www.scopus.com/inward/record.url?scp=85077875884&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-0707-2

DO - 10.1038/s41375-020-0707-2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31937894

AN - SCOPUS:85077875884

SN - 0887-6924

VL - 34

SP - 1970

JO - Leukemia

JF - Leukemia

IS - 7

ER -

Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuela JM, Schäfer B, Spinelli O et al. Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0). Leukemia. 2020 Jul 1;34(7):1970. doi: 10.1038/s41375-020-0707-2

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this